Korea Investment Partners

1 stories about Korea Investment Partners
default image

Cell Immunotherapy Company Raises $8 Million

24.09.17|Lilach Baumer
Enlivex Therapeutics Ltd. is a clinical-stage company specializing in autoimmune and inflammatory conditions